The End of Untreatable.
Cambridge, MA
Joined October 2021
- Tweets157
- Following481
- Followers146
- Likes28
Pinned Tweet
"This emphasis on transomics is the future.” Check out CEO @JonYuHu’s recent interview with @GenomeWeb to learn how Pepper Bio is leveraging transomics to better understand biological processes and develop precision medicine. #DrugDiscovery #Transomics
bit.ly/3wbqKmR
We’ve reached a milestone in our mission to discover new treatments for untreatable diseases. We’re licensing lerociclib from @G1Therapeutics to test it as a new liver cancer therapeutic—and we’re already seeing promising results. More via @FierceBiotech: fiercebiotech.com/biotech/pe…
Pepper Bio’s Caitlin Brown will be taking part in #REpharmaUSA 🚀 She’ll be looking to dive into AI in drug discovery & precision medicine discussions. Attending? Let's connect!
#AI in #biotech: not a cure-all, but a powerful tool when combined with human expertise, leading to breakthroughs in disease treatment. The synergy between AI and scientists' insights is where real magic lies. Dive deeper via @STAT @caseymross bit.ly/3Tdl2Nr
Exciting developments at @UVACancerCenter! #Machinelearning now identifies high-risk #AML patients by analyzing cancer cell bioactive molecules. Personalized treatment is the future, ensuring safer, more effective care bit.ly/430pEJZ
FDA's approval of repotrectinib marks a new chapter in lung cancer therapy, targeting ROS1 fusions with precision. This advancement aligns with our mission—pushing the boundaries of patient-specific treatment and showcasing the power of #precisionmedicine bit.ly/3UisDLA
🧬Thank you @HealthTechX for selecting Pepper Bio as a finalist in the Innovator category! We’re dedicated to making ‘untreatable diseases’ a thing of the past. Congrats to our fellow finalists!
Embracing the transformative power of #AI, we're redefining drug discovery at Pepper Bio with efficiency and precision. Mindful of the challenges, we're committed to ethical innovation. Explore AI's future in healthcare in @ClinicalLeader1: bit.ly/4bcjcmR
Precision medicine is more than a concept—it's a revolution in healthcare. With a focus on individual biology, we're redefining treatment for complex diseases. Dive into Dr. Jennifer Levin Carter's insights on #precisionmedicine: bit.ly/3HAgcmI
With a growth rate of 40.2% and revenue expected to hit $4.9B by 2028, AI is reshaping #precisionmedicine, from molecule design to target research. More in @Politico on AI redefining #drugdiscovery: bit.ly/3ttIdJe
#AI is revolutionizing #clinicaltrials, moving beyond traditional RCTs that slow down therapy development. This isn't just tech evolution, it's a healthcare paradigm shift towards more personalized, efficient treatments. Dive into the full insights: bit.ly/480Qvr3
At #JPM2024, our CEO @jonyuhu shared with @PharmaVoice's @MeaganParrish his perspective on what policies will shape biotech in 2024. '"It's not the first time we've heard of march-in rights, but [they] are more mainstream now,' he says. More here: bit.ly/3ScB21H
Pepper Bio retweeted
Energized by @pepper_bio's feature in @TechCrunch's Pitch Deck Teardown! @Haje's review of our $6.5M seed pitch highlights our mission to treat untreatable diseases. Haje’s praise of our market size slide reflects our areas of commitment bit.ly/3tGM31X
Kicking off 2024 with a feature in @TechCrunch's Pitch Deck Teardown! Thanks to @Haje for the insightful review of our $6.5M seed deck. bit.ly/3tGM31X
We’re welcoming Dr. Martin Alexander Gershon (@endeavorfunds), a renowned neuroscientist, oncologist, and investor, as an advisor to our team! Read more here: bit.ly/48lFH7j
#drugdiscovery #biotech #transomics
Are you headed to #JPM2024? Meet with our Head of Development, Caitlin Brown! Caitlin can catch you up on Pepper’s pipeline, partnerships, and research developments this year. Send us a DM to connect or email [email protected].
Pepper Bio retweeted
See how NFX-backed @pepper_bio and @PangeaBiomed are using AI to help develop better cancer drugs in @WSJ:
wsj.com/articles/startups-ar…
“We don’t think the right question is if AI will impact drug discovery, but how and when,” @Jonyuhu said. Jon and @SamanthaDStrass share more on how AI will transform the industry with @BrianPGormley via @WSJ tinyurl.com/4csubdz8
#AI breakthrough by @UCL & @Cambridge_Uni in #lungcancer risk prediction. This study shows AI's potential to streamline screenings, aiding early detection & treatment. We applaud these advances in healthcare. More here: bit.ly/412cDi4
Our CEO @Jonyuhu explores how we must redirect the power behind patient advocacy groups to focus on bringing drugs to market that are clinically proven to be effective. Read his proposed solutions in @statnews: statnews.com/2023/12/18/pati…
